GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (TSX:AEZS) » Definitions » PS Ratio

AEterna Zentaris (TSX:AEZS) PS Ratio : 2.14 (As of Apr. 30, 2024)


View and export this data going back to 1995. Start your Free Trial

What is AEterna Zentaris PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, AEterna Zentaris's share price is C$2.67. AEterna Zentaris's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$1.25. Hence, AEterna Zentaris's PS Ratio for today is 2.14.

The historical rank and industry rank for AEterna Zentaris's PS Ratio or its related term are showing as below:

TSX:AEZS' s PS Ratio Range Over the Past 10 Years
Min: 0.87   Med: 10.19   Max: 3950
Current: 2.14

During the past 13 years, AEterna Zentaris's highest PS Ratio was 3950.00. The lowest was 0.87. And the median was 10.19.

TSX:AEZS's PS Ratio is ranked better than
83.99% of 993 companies
in the Biotechnology industry
Industry Median: 9.09 vs TSX:AEZS: 2.14

AEterna Zentaris's Revenue per Sharefor the three months ended in Dec. 2023 was C$0.03. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$1.25.

Warning Sign:

AEterna Zentaris Inc revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of AEterna Zentaris was -21.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was -24.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was -40.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -24.90% per year.

During the past 13 years, AEterna Zentaris's highest 3-Year average Revenue per Share Growth Rate was 129.60% per year. The lowest was -91.20% per year. And the median was -18.20% per year.

Back to Basics: PS Ratio


AEterna Zentaris PS Ratio Historical Data

The historical data trend for AEterna Zentaris's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris PS Ratio Chart

AEterna Zentaris Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.72 4.74 7.76 2.72 2.07

AEterna Zentaris Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.72 1.92 1.38 1.76 2.07

Competitive Comparison of AEterna Zentaris's PS Ratio

For the Biotechnology subindustry, AEterna Zentaris's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AEterna Zentaris's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AEterna Zentaris's PS Ratio distribution charts can be found below:

* The bar in red indicates where AEterna Zentaris's PS Ratio falls into.



AEterna Zentaris PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

AEterna Zentaris's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=2.67/1.248
=2.14

AEterna Zentaris's Share Price of today is C$2.67.
AEterna Zentaris's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.25.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


AEterna Zentaris  (TSX:AEZS) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


AEterna Zentaris PS Ratio Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AEterna Zentaris (TSX:AEZS) Business Description

Traded in Other Exchanges
Address
222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.